The MIND Foundation Resources consist of three main segments: Psychedelic Compendium, Multimedia Trove, and the Berlin Registry.

The Resources section was created to give an up-to-date overview of German and international journalistic coverage, high-quality research publications, as well as further media on psychedelic research topics. 

Enjoy our documentation of growing academic interest in psychedelic experience, and its applications in the medical field as well as self-development processes. 

Our Resources for you: 

The Psychedelic Compendium comprises carefully curated and annotated readings on key topics in psychedelic research and implementation. Among these are four categories:

  • Lists for Researchers,
  • Lists for Physicians & Therapists, 
  • and Lists for Press & Journalists,
  • and Lists for Patients. 

The first two categories summarize scientific publications. Reading Lists for Press & Journalists comprise high-quality journalistic publications from the German and international context. The category of Lists for Patients includes a mix of educational literature.

The Multimedia Trove presents a selection of recommended non-fiction literature, biographies and fiction, podcasts, feature films, and documentaries related to psychedelic research, society, and cultural history. 

The Berlin Registry is a regularly updated overview of companies that are involved in the psychedelic industry worldwide. The interactive map provides an insight into currently active companies and their ongoing projects. 

Enjoy browsing our resources!

Psychedelic Compendium

Further Resources

Research Instruments

Presented here are a variety of tools that assist scientific inquiry, such as questionnaires. Some of these research instruments have been created by those in the MIND family, while some are shared by our collaborators.

Find out more

BERLIN REGISTRY

The Berlin Registry is an interactive and regularly updated overview of companies that are involved in the psychedelic industry worldwide. Our interactive map provides an insight into currently active companies and their ongoing projects.

Find out more

MULTIMEDIA TROVE

The Multimedia Trove presents a selection of recommended non-fiction literature, biographies and fiction, podcasts, feature films, and documentaries related to psychedelic research, society, and cultural history.

Find out more

MIND BLOG

We support and conduct high-quality psychedelic research

The MIND Foundation’s research projects are geared towards evidence-based practice and high-quality science. For many of these projects, we are working together with universities in and outside of Germany and in collaboration with our Scientific Advisory Board. We invite you to explore our current projects, which are listed below.

 RKE-FELLOWSHIP_hero_silhouttes-2_no-text  RKE-FELLOWSHIP_hero_silhouttes-2_no-text

COOPERATION PARTNER IN PSILOCYBIN DEPRESSION STUDY

Principal investigator Prof. Dr. med. Gerhard Gründer has received the final approval for a psilocybin depression study (EPIsoDE) at the Central Institute of Mental Health Mannheim and the Charité Universitätsmedizin Berlin.  The MIND Foundation is a cooperation partner in the EPIsoDE study.

Find Out More
 RKE-FELLOWSHIP_hero-movement_no-text  RKE-FELLOWSHIP_hero-movement_no-text

Studies & Surveys

Find out more about participation in studies and online surveys. You will find studies & surveys that are directly supported by MIND as well as those conducted by other universities and institutes, which are featured here.

Find out more
 RESOURCES_hero (1)  RESOURCES_hero (1)

Resources

Psychedelic research has implications for a wide range of people and professions. Check out some useful resources for newcomers and those looking to deepen their understanding of the subject.

Find out more
 UNIMIND_hero  UNIMIND_hero

UNIMIND

uniMIND sets up academic journal clubs across the world to discuss psychedelic research. Students as well as senior academics of any level and any background are invited to engage in critical discourse on altered states of consciousness and psychedelics.

Find Out More

MIND Awards

In recognition of outstanding contributions to the psychedelic research and therapy field, we award young and established academics prizes of various kinds. Usually at the INSIGHT conference.

Learn more

Research Fellowships

The MIND Foundation’s Research Fellowship program 2020 provides two fellowships for doctoral students.

Learn more
 blog-treated_Yaden  blog-treated_Yaden

Combining Psychedelics and 12-Step Programs for Substance Use Disorders

  • Blog
  • Science
  • Interview
  • 7 minutes
Novembro 12, 2021
Share

Incoming Assistant Professor

David currently studies the subjective and behavioral effects of psychedelic substances as well as their treatment potential.

View full profile ››

Ph.D. Candidate

Lukas Basedow's research is in the field of adolescent substance abuse at the medical faculty of the TU Dresden.

View full profile ››

This interview is about the following publication: Yaden, D. B., Berghella, A. P., Regier, P. S., Garcia-Romeu, A., Johnson, M. W., & Hendricks, P. S. (2021). Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. International Journal of Drug Policy, 98, 103380.

Treatment for people with substance use disorders is often based on classical psychotherapeutic principles, such as cognitive-behavioural therapy. However, two unorthodox approaches have existed since the 1950s that, at first glance, seem to incorporate opposing principles: 12-step abstinence-based programs and psychedelic therapy. In this interview, I exchange with David Yaden, PhD, who recently published a paper with his colleagues from John Hopkins University, in which they discuss potential synergies between these two treatment modalities.

L: For our readers who may be are unaware of this concept, could you shortly explain what 12-step programs are?

D: 12-step programs are peer-support groups that follow a guiding set of principles to help members maintain sobriety. Alcoholics Anonymous (AA) was the first 12-step program, and probably the one that most people are familiar with. Nowadays, there are 12-step groups intended to help with most addictive drugs as well as behaviors like gambling.

12-step groups sit a little uneasily with mainstream addiction treatments. While many clinicians encourage their patients to seek out 12-step groups as an adjunct to evidence-based therapies or treatments, 12-step programs are not themselves considered part of medical or clinical treatments. Moreover, many 12-step programs do not allow members to participate in some evidence-based drug treatments such as medication assisted treatments (e.g., methadone), which is considered a controversial practice among evidence-based clinicians and researchers who see this as preventing effective treatment. Lastly, a large Cochrane review showed that there is evidence suggesting that 12-step programs are effective for some people.1 There are a complex set of dynamics at play here.

L: What do you think is the broad appeal of 12-step programs? Why has this program been able to spread successfully across the whole globe?

D: 12-step programs benefit from its members, who are often extremely engaged and can provide social connection and support to people who are often lacking it in their lives. The social support that many 12-step programs provide goes well beyond the amount of time that clinicians can provide due to the constraints of their schedules. For example, 12-step program members are teamed with another 12-step program member, who plays the role of a “sponsor.” New members can generally call their sponsor at any hour, day or night, if they are tempted to relapse or if they simply need someone to talk to.

Additionally, the 12-steps themselves are very easy to understand, and provide as their name implies, a step-by-step process to regain sobriety and remain sober.

Finally, 12-step programs are usually easily accessible and free, while healthcare resources can sometimes be inaccessible and/or difficult to afford in the US.

L: The 12-step programs explicitly mention spiritual experiences as catalysts of change. Could you elaborate on what is meant by that?  What is considered a spiritual experience in 12-step programs and how does this experience differ from or is similar to experiences induced by psychedelic substances?

D: The 12-step programs stem from Bill Wilson’s writings. Bill Wilson (b. 1895 – d. 1971) co-founded Alcoholics Anonymous (AA) after he achieved sobriety during a moment that he considered a “spiritual experience.” Here is Bill Wilson describing his experience:

“Slowly the ecstasy subsided. I lay on the bed, but now for a time I was in another world, a new world of consciousness. All about me and through me was a wonderful feeling of Presence. A great peace stole over me and I thought, “No matter how wrong things seem to be, they are all right…” (quoted by Ernest Kurtz2)

Notably, Bill Wilson was being treated with a substance called Scopolamine, which some consider a psychedelic (though it is not a classic psychedelic like psilocybin or LSD). He was undergoing treatment for alcoholism in a New York City hospital under the care of a physician who was attempting a new form of treatment. Most people are unaware that Bill Wilson’s first spiritual experience occurred under the influence of a psychedelic-like substance!

Spiritual experience plays a prominent role in 12 step programs. After all, it’s part of the 12 steps. The 12th and final step reads: “Having had a spiritual experience as the result of these steps, we tried to carry this message to alcoholics, and to practice these principles in all our affairs.”3

L: With regards to your paper: What led you to think that synergies between psychedelic use and 12-steps programs could exist?

D: The spiritual experience that Bill Wilson described as prompting his sobriety is very similar to the subjective effects reported by many people taking psychedelics.  Bill himself made this point. Later in his life, Bill tried LSD (a classic psychedelic) under the care of a physician. He appeared to benefit from these psychedelic treatments, and Wilson provided a positive endorsement:

“It is a generally acknowledged fact in spiritual development that ego reduction makes the influx of God’s grace possible If, therefore, under LSD we can have a temporary reduction, so that we can better see what we are and where we are going – well, that might be of some help. The goal might become clearer. So I consider LSD to be of some value to some people, and practically no damage to anyone.” 4

Wilson’s endorsement of psychedelic treatments may surprise people – it certainly surprised us when we learned about it. According to one scholar, Joe Miller, who wrote US of AA, this fact may have even been actively suppressed by the board of AA.

L: So, what actual synergies do you see? Do you believe there is a benefit to combining the two approaches?

D: I want to be very clear on this point – in the paper, we are neither advocating nor denouncing the combination of psychedelics with 12-step programs.

However, we can’t help but notice the substantial similarities between psychedelic treatments, which many people report resulting in a spiritual-type experience, and the aims of 12-step programs, which aim to provide a kind of spiritual experience as a result of working the steps.

We thought it was interesting that 12-step programs tend to disallow members from participating in medication assisted treatments (MAT) because they are seen as “swapping one drug for another.” This can be unfortunate considering that MAT has been shown to be among the most effective ways of keeping people who have substance use disorders alive.

We were curious as to whether some 12-step programs might make an exception for treatments with psychedelics. Indeed, while they are drugs or kinds of medication, they provide experiences that are similar to (or identical to in some cases) the spiritual experiences that are at the heart of 12-step programs. Meanwhile, the founder of AA advocated combining 12-step programs with psychedelic treatments – and it could be that knowing about this endorsement from AA’s founder might be impactful or at least interesting to some members of 12-step programs.

L: Regarding the integration of psychedelics into 12-steps: What would the actual practice look like? How could psychedelics be integrated into a 12-step program?

D: We could imagine a few different possibilities – call the possible models initiatory, intermittent, or culmination. An initiatory model would suggest undergoing a psychedelic experience toward the beginning of the 12-step process in order to provide more motivation during what may be a difficult period of transition. An intermittent model might involve periodically engaging in psychedelic treatments over the course of the 12-step process, maybe once every few months or so, in order to maintain the momentum of treatment and sobriety. Lastly, a culmination model might involve having the psychedelic treatment along with the 12th and final step as a kind of capstone to, and opportunity to reflect on, the entire process.

Again, these are just some possibilities, we don’t really know how this integration might look in the real world. It’s a topic that’s worth studying and would require interdisciplinary teams to do the research well. Let me reiterate that both here and in the paper, we are neither advocating or denouncing the combination of psychedelics with 12-step programs, but merely considering the subject.

L: What do you think the next steps would look like for this line of research? What are important aspects about this combination that need to be explored?

D: We’re launching some research projects to study groups that are apparently already engaged in integrating psychedelics into the 12-step process. Yet again, I want to reiterate that we’re not supporting or condoning integrating psychedelics into 12-step groups (it is currently illegal in the US and therefore legally risky). But we do want to learn more about this practice – the potential safety issues that come up, whether it’s effective, and how the integration fits with 12-step philosophy as well as with current mainstream evidence-based treatments. There are a number of interesting and important psychological, medical, legal, and anthropological questions to address in this framework.

L: Finally, what would the best possible care for patients with substance use disorders look like? What do you envision the ideal future of treatment to look like?

D: I am a psychological and psychopharmacological researcher, so I study psychological and pharmacological interventions. I think there is a great deal of progress that can be made on both of these fronts. It’s important to note that there are treatments currently available for people who suffer from substance use disorders, and I encourage this population to take advantage of these existing evidence-based treatments.

Learn more about substance use disorders on MIND’s Elements of Science.

At our lab at Johns Hopkins, the Center for Psychedelic and Consciousness Research, we are conducting studies and collecting promising data on the potential efficacy of psychedelics for the treatment of substance use disorders. We need more and better research to follow-up on preliminary findings (something that researchers like Matt Johnson, Albert Garcia-Romeu, and Peter Hendricks are currently working on), but it does seem that psychedelics have the potential to help treat some patients with substance use disorders. On the other hand, community-based peer support groups like 12-step programs also appear to be effective, as the recent Cochrane review showed.

Ultimately, though, several larger social forces and policy-related issues need to be addressed to allow people with substances use disorders to obtain access to the services and resources they need.

To summarize, “the best possible care for substance use disorders” would likely involve the integration of access to economic resources and social services. The same goes for psychological and pharmacological treatments. There are no easy or simple solutions here.

The aim of our paper was to highlight a somewhat complicated situation – integrating psychedelics into 12-step programs – and to try to understand their dynamics a little better. I think we probably succeeded more in raising questions than we did at providing concrete answers.

Our work at MIND relies on donations from people like you.

If you share our vision and want to support psychedelic research and education, we are grateful for any amount you can give.

  1. Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12‐step programs for alcohol use disorder. Cochrane Database Syst Rev [Internet]. 2020 [cited 2021 Sep 30];(3). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012880.pub2/full
  2. Kurtz E. A.A.: The Story by Ernest Kurtz. Harpercollins; 1988.
  3. Alcoholics Anonymous. Alcoholics Anonymous Big Book. 4th ed. Hazelden; 2001.
  4. Hartigan F. Bill W.: A Biography of Alcoholics Anonymous Cofounder Bill Wilson. Thomas Dunne Books; 2000. 256 p.

Die Ressourcen der MIND Foundation bestehen aus drei Hauptsegmenten: Psychedelic Compendium, Multimedia Trove und die Berlin Registry.

Die Rubrik Ressourcen wurde geschaffen, um einen aktuellen Überblick über deutsche sowie internationale journalistische Berichterstattung, hochwertige Forschungspublikationen und weitere Medien zu psychedelischen Forschungsthemen zu geben.

Nutzen Sie unsere Dokumentation der wachsenden akademischen Beschäftigung mit psychedelischen Erfahrungen und deren Anwendungen im medizinischen Bereich und Selbstentwicklungsprozessen.

Unsere Ressourcen für Sie:

Das Psychedelic Compendium umfasst sorgfältig kuratierte und kommentierte Literatur zu wichtigen Themen der psychedelischen Forschung und Anwendung. Darunter befinden sich vier Kategorien:

  • Listen für Forschende,
  • Listen für Ärzte & Therapeuten,
  • und Listen für Presse & Journalisten,
  • und Listen für Patienten.

Die ersten beiden Kategorien fassen wissenschaftliche Publikationen zusammen. Die Leselisten für Presse & Journalisten umfassen hochwertige journalistische Publikationen aus dem deutschen und internationalen Kontext. Die Kategorie Listen für Patienten enthält einen Mischung informativer Literatur.

Die Multimedia Trove präsentiert eine Auswahl an empfehlenswerter Sachliteratur, Biografien und Belletristik, Podcasts, Spielfilmen und Dokumentationen mit Bezug zur psychedelischen Forschung, Gesellschaft und Kulturgeschichte.

Die Berlin Registry ist eine regelmäßig aktualisierte Übersicht über Unternehmen, die weltweit in der psychedelischen Industrie tätig sind. Die interaktive Karte gibt einen Einblick in derzeit aktive Firmen und ihre laufenden Projekte.

Wir wünschen Ihnen viel Freude beim Durchstöbern unserer Ressourcen!

Psychedelic Compendium

Further Resources

Weitere Ressourcen

Forschungsinstrumente

Hier werden eine Reihe von Instrumenten vorgestellt, die die wissenschaftliche Untersuchung unterstützen, wie z. B. Fragebögen. Einige dieser Forschungsinstrumente wurden von den Angehörigen der MIND-Familie erstellt, während andere von unseren Kooperationspartnern zur Verfügung gestellt wurden.

Research Instruments

BERLIN REGISTRY

Die Berlin Registry ist eine interaktive und regelmäßig aktualisierte Übersicht über Unternehmen, die in der psychedelischen Industrie tätig sind. Unsere interaktive Karte gibt einen Einblick in aktuell aktive Unternehmen und deren laufende Projekte.

The Berlin Registry

MULTIMEDIA TROVE

Die Multimedia Trove präsentiert eine Auswahl empfehlenswerter Sachliteratur, Biografien und Belletristik, Podcasts, Spielfilmen und Dokumentationen mit Bezug zur psychedelischen Forschung, Gesellschaft und Kulturgeschichte.

Multimedia Trove
Wir unterstützen und führen hochwertige psychedelische Forschung durch

Die Forschungsprojekte der MIND Foundation sind auf evidenzbasierte Praxis und qualitativ hochwertige Wissenschaft ausgerichtet. In vielen unserer Projekte arbeiten wir gemeinsam mit Universitäten in- und außerhalb Deutschlands, sowie in Zusammenarbeit mit unserem wissenschaftlichen Beirat. Wir laden Sie ein, sich über unsere aktuellen Projekte zu informieren, die im Folgenden aufgeführt sind.

 RKE-FELLOWSHIP_hero_silhouttes-2_no-text  RKE-FELLOWSHIP_hero_silhouttes-2_no-text

Psilocybin-Depressionsstudie

Die geplante Studie wurde initiiert und wird geleitet von Studienleiter Prof. Dr. med. Gerhard Gründer am Zentralinstitut für Seelische Gesundheit Mannheim des Universitätsklinikums Heidelberg. Wir arbeiten mit beiden Studienzentren in Mannheim und an der Klinik für Psychiatrie und Psychotherapie der Charité Universitätsmedizin Berlin zusammen.

Erfahren Sie mehr
 RKE-FELLOWSHIP_hero-movement_no-text  RKE-FELLOWSHIP_hero-movement_no-text

Studien & Umfragen

Erfahren Sie mehr über die Teilnahme an Studien und Online-Umfragen. Sie finden hier sowohl Studien & Umfragen, die direkt von MIND unterstützt werden, als auch solche, die von anderen Universitäten und Instituten durchgeführt werden, die hier vorgestellt werden.

Erfahren Sie mehr
 RESOURCES_hero (1)  RESOURCES_hero (1)

RESSOURCEN

Die psychedelische Forschung hat Implikationen für ein breites Spektrum von Menschen und Berufen. Wir stellen nützliche Ressourcen zur Verfügung und erweitern diese ständig.

Für Neulinge und diejenigen, die ihr Verständnis des Themas vertiefen möchten.

Erfahren Sie mehr
 UNIMIND_hero  UNIMIND_hero

UNIMIND

Mit uniMIND entstehen weltweit akademische Journalclubs zur Diskussion psychedelischer Forschung. Sowohl Studierende als auch höherrangige Akademiker sind eingeladen, sich am kritischen Diskurs über veränderte Bewusstseinszustände und Psychedelika zu beteiligen.

Erfahren Sie mehr

MIND Awards

In Anerkennung herausragender Beiträge zum Feld psychedelischer Forschung und Therapie verleihen wir jungen sowie etablierten WissenschaftlerInnen Preise unterschiedlicher Art. Die Verleihung findet in der Regel auf der INSIGHT Konferenz statt.

Erfahren Sie mehr

Forschungsstipendien

Die MIND Foundation stellt jährlich Stipendien für Doktoranden zur Verfügung.

Erfahren Sie mehr

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS

Over the course of six weeks, you will reconnect deeply with one of your psychedelic experiences in order to identify and embody the insights you have gained in sustainable ways. To support you in unfolding both the challenging and the beneficial aspects you may have uncovered, you will be guided through the integration process in six structured steps. Each week will cover one specific aspect and the modules will build on each other, progressing from intention to transformation.

The live webinars will happen once a week for six consecutive weeks, starting on June 1st, 8pm.

The peer group meetings are intended to take place on Sundays from 6pm to 7.30pm (CET) as a follow up to the live webinar sessions. However, the dates for the peer group meetings can be changed, according to the needs of the participants.

You can join from everywhere in the world!

 

Get your ticket here: Footsteps on MIND Academy Online
The ticket price includes the whole course with all six live sessions and access to all recordings, course resources, additional material and access to the course platform.

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS

The Coaching & Psychedelics Section offers monthly drop-in sessions for new members with the aim to share thoughts, ideas, questions, concerns, feelings, and resources. We’re exploring what a methodology in this area may look like and what coaches need to consider in order to work ethically, legally, and professionally with clients who may contact them to seek support around their psychedelic experiences.

WHO IS THIS GROUP FOR?

Ideally you’ll be a qualified and practicing coach, but therapists, other healthcare professionals or anybody with an interest in coaching & psychedelics is welcome to join.

WHAT WE WILL BE TALKING ABOUT IN THESE MEETINGS
The overarching question we have is: What is the potential for psychedelics and coaching to work together as to benefit coaches, clients and the wider society. In order to explore this question we’ll have conversations about the topics and questions listed below, we’ll share experiences from coaching practice, challenge and question each other, debate, support and, together, advance the knowledge in our field, industry or individual practice. If you’re joining for the first time we’ll ask you to introduce yourself and your interest in the field and to contribute to this conversation any way you can.

TOPICS AND QUESTIONS WE’D LIKE TO DISCUSS